Q32 Bio (QTTB) Share-based Compensation Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 15.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.35% |
| Dec 31, 2025 | 17.43% |
| Sep 30, 2025 | -14.91% |
| Jun 30, 2025 | -5.09% |
| Mar 31, 2025 | 221.82% |
| Dec 31, 2024 | 140.12% |
| Sep 30, 2024 | 359.14% |
| Jun 30, 2024 | 330.97% |
| Mar 31, 2024 | 40.88% |
| Dec 31, 2023 | -83.13% |
| Sep 30, 2023 | -89.14% |
| Jun 30, 2023 | -90.14% |
| Mar 31, 2023 | -92.69% |
| Dec 31, 2022 | -33.76% |
| Sep 30, 2022 | -34.43% |
| Jun 30, 2022 | -29.73% |
| Mar 31, 2022 | 4.33% |
| Dec 31, 2021 | 30.76% |
| Sep 30, 2021 | 26.30% |
| Jun 30, 2021 | 29.58% |
| Mar 31, 2021 | 34.69% |
| Dec 31, 2020 | 46.39% |
| Sep 30, 2020 | 68.39% |
| Jun 30, 2020 | 75.32% |
| Mar 31, 2020 | 131.94% |
| Dec 31, 2019 | 155.08% |
| Sep 30, 2019 | 176.36% |
| Jun 30, 2019 | 246.05% |
| Mar 31, 2019 | 227.11% |
| Dec 31, 2018 | 493.69% |
| Sep 30, 2018 | 1,142.14% |
| Jun 30, 2018 | 1,760.81% |
| Mar 31, 2018 | 1,272.83% |